Compare CBC & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CBC | RGEN |
|---|---|---|
| Founded | 1902 | 1981 |
| Country | United States | United States |
| Employees | 3036 | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4B | 6.6B |
| IPO Year | N/A | 1995 |
| Metric | CBC | RGEN |
|---|---|---|
| Price | $29.48 | $145.13 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 12 |
| Target Price | $28.67 | ★ $167.67 |
| AVG Volume (30 Days) | 792.5K | ★ 971.4K |
| Earning Date | 04-28-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.21% | N/A |
| EPS Growth | N/A | ★ 286.96 |
| EPS | N/A | ★ 0.15 |
| Revenue | N/A | ★ $141,236,000.00 |
| Revenue This Year | $12.15 | $14.30 |
| Revenue Next Year | $6.34 | $14.52 |
| P/E Ratio | ★ $14.38 | $968.40 |
| Revenue Growth | N/A | ★ 35.10 |
| 52 Week Low | $22.50 | $100.99 |
| 52 Week High | $29.92 | $175.77 |
| Indicator | CBC | RGEN |
|---|---|---|
| Relative Strength Index (RSI) | 62.68 | 70.07 |
| Support Level | $26.86 | $141.44 |
| Resistance Level | N/A | $172.45 |
| Average True Range (ATR) | 0.85 | 6.22 |
| MACD | 0.06 | 1.41 |
| Stochastic Oscillator | 85.11 | 85.92 |
Central Bancompany Inc is a bank holding company that provides a broad range of retail, corporate, mortgage banking, wealth management, and trust products and services to individuals and businesses. Its operating segments include Consumer, Commercial, and Wealth Management. The company generates the majority of its revenue from the Commercial segment, which provides full-service relationship banking solutions to businesses, agencies, and community organizations, including commercial, small business, and government clients. The segment also offers business payment solutions such as treasury management services, merchant services, and commercial bank card products.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.